Healthcare

By

Timothy Collins

 | Apr 19, 2018 | 12:27 PM EDT
Consider this trade only after the price triggers.
By

Bret Jensen

 | Apr 18, 2018 | 1:00 PM EDT
A look at three names to consider in the biotech and biopharma space.
RMPIA
By

James "Rev Shark" DePorre

 | Apr 17, 2018 | 1:22 PM EDT
The game plan is to spot the charts that have more room to run.
RMPIA
By

Bret Jensen

 | Apr 16, 2018 | 2:26 PM EDT
Data and industry conferences will likely be catalysts for shares in the space.
By

Timothy Collins

 | Apr 12, 2018 | 3:52 PM EDT
When this stock hit my breakout scan, I paid it a bit of extra attention.
RMPIA
By

Bret Jensen

 | Apr 11, 2018 | 1:00 PM EDT
Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.
By

James "Rev Shark" DePorre

 | Apr 11, 2018 | 10:49 AM EDT
Wall Street discounting talk of bombing Syria from president.
By

Bruce Kamich

 | Apr 11, 2018 | 8:43 AM EDT
Sometimes you miss trades or investments if you don't take a step back.
By

Bruce Kamich

 | Apr 10, 2018 | 3:42 PM EDT
Chart indicators suggest Anthem may be ready for run at $300.
RMPIA
By

Jim Cramer

 | Apr 4, 2018 | 6:53 PM EDT
Stock markets ran higher as investors turned towards domestic-focused companies.
Interest rates are up (TLT down) which is causing strength in the Dollar (UUP) because fit...
Twitter (TWTR) has been an interesting trading vehicle recently and it is on my radar agai...
With much of the chatter about rising bond yields, I wanted to compare what is happening n...
Looking like a tough open, but not as brutal as you would expect after Tuesday.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.